Skip to main content

NASDAQ: AGRX Agile Therapeutics Anticipates Increased Growth In Q3 of 2022

Contact Details

Matt Riley - Head of Investor Relations & Corporate Communications

mriley@agiletherapeutics.com

Company Website

https://agiletherapeutics.com/

Recent Quotes

View More
Symbol Price Change (%)
AMZN  254.93
+10.71 (4.38%)
AAPL  267.61
-2.76 (-1.02%)
AMD  257.87
+1.75 (0.68%)
BAC  53.41
-0.05 (-0.08%)
GOOG  283.20
+1.38 (0.49%)
META  644.41
-3.94 (-0.61%)
MSFT  516.12
-1.68 (-0.33%)
NVDA  207.99
+5.50 (2.71%)
ORCL  258.12
-4.49 (-1.71%)
TSLA  466.13
+9.57 (2.10%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.